KRAS and pancreatic neoplasm: However, these mechanisms underlying activation of mitochondrial ROS generation can be associated to a rewiring of the mitochondrial metabolism of tumor cells [e.g., MYC/KRAS or MYC/ERBB2 ablation in breast and pancreas cancer cells (5–7)].